Press Releases
What do you view as the most disruptive or transformational technology or development on the horizon?
As more types of modalities such as ADCs, bsAbs, AAVs, and mRNA surface on the market, biopharma companies are looking for new ways to reach drug targets. In this roundtable with Pharma’s Almanac, Hyungseok Choi, our Head of Advanced Research, shares his insights on how evolving technology will impact biologics development.
Read more
As more types of modalities such as ADCs, bsAbs, AAVs, and mRNA surface on the market, biopharma companies are looking for new ways to reach drug targets. In this roundtable with Pharma’s Almanac, Hyungseok Choi, our Head of Advanced Research, shares his insights on how evolving technology will impact biologics development.
Read more